Wanbury gets fresh USFDA clearance for Patalganga plant

Mumbai, Aug 19 (UNI) Wanbury today announced that they have received a renewed approval from the US Foods and Drugs Authority (USFDA) for its multi product Active Pharmaceutical Ingredients (API) facility at Patalganga.

The company informed the BSE, that they would manufacture three new products, Tramadol, Amytriptyline and Paroxetine.

The plant at Patalganga in Maharashtra would continue to manufacture existing products like Metformin and Salsalate, it said and pointed out this plant had received the USFDA approval earlier in 2002, too.

UNI SN WD SKB1809